NewsLife Sciences
Bioanalytical fit-for-purpose solutions for preclinical and clinical development –Mercodia webinar
Watch this on demand webinar to help produce cost- and time- effective bioanalytical strategies
13 Jan 2023
Lawrence Howes
Editorial Assistant
Industry news

Biomarkers and pharmacokinetic/pharmacodynamic (PK/PD) studies play key roles in the drug development process, with the potential to improve the success rate and, reduce uncertainty in regulatory decisions.
Understanding the specific context of the use of a biomarker is essential for designing a cost- and time-effective bioanalytical strategy.
In this free on-demand webinar, Carmen Herrera Hidalgo, Global Product Manager at Mercodia Services, discusses:
- How to tailor the bioanalytical strategy to fit the study needs.
- How to ensure a successful method validation outcome.
- Register for this expert webinar to find out how Mercodia is uniquely positioned to help solve real-life bioanalytical challenges.

Want the latest science news straight to your inbox? Become a SelectScience member for free today >>
Links
Tags
Sample PreparationSample preparation can improve the quality and speed of separation techniques. Products to assist sample preparation include filtration equipment, evaporators, membranes and sieves.Sample ManagementSample management systems include sample storage devices such as freezers and plate storers, sample environment enclosures and sample organization, retrieval and sorter systems. Useful system features include high-throughput, automation, robotic arms, automated liquid handling and associated database systems. Accessories in sample management include barcode scanners, heat sealers and tubes.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.PharmacokineticsBiomarker DiscoveryClinical biomarkers refer to substances related to known medical conditions that can be accurately measured <i>in vitro</i>. Biomarkers can be used to diagnose presence of a disease and indicate disease severity. The discovery of new biomarkers is incredibly valuable in the field of diagnostics.